Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Droperidol vs Ondansetron for Postoperative Akathisia in Outpatient Surgery
NCT01942343Phase 3Completed
- Sponsor
- Strasbourg University Hospital
- Start
- Oct 2013
- Primary completion
- Oct 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of droperidol in postoperative nausea and vomiting (PONV) (3 arms), sponsored by Strasbourg University Hospital. Primary endpoint: Incidence of akathisia at 1 day. Started Oct 2013; status: completed.
02
Drugs
droperidol
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT01942343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01942343.